Kunal Gandhi

Kunal Gandhi serves as the Vice President of Global Clinical Development and Therapeutic Head for Nephrology and Immunology at Otsuka Pharmaceutical Companies (U.S.) since February 2023. Previously, Kunal Gandhi held various clinical development roles at Novartis from July 2015 to March 2023, including Global Clinical Program Head for Immunology. Kunal Gandhi has extensive experience in medical affairs and clinical development, with leadership roles at Bristol-Myers Squibb and GlaxoSmithKline. In addition, Kunal Gandhi has contributed to academia as an Adjunct Faculty Member at Rutgers Robert Wood Johnson Medical School since August 2011 and previously as an Instructor of Psychiatry at UMDNJ. Educational qualifications include a Master of Public Health in Epidemiology from UMDNJ School of Public Health and a Doctor of Medicine from the University of Mumbai.